KLF2 and diabetic kidney disease: An interesting study showed that podocyte loss was also increased in diabetic KLF2EC/+ mice compared to diabetic wild‐type mice, suggesting that KLF2 is involved in GEnCs‐podocytes cross talk and that targeting KLF2 may be a novel strategy to prevent DKD progression.88